Review Special Issues

The role of the gut microbiome in paediatric irritable bowel syndrome

  • Received: 31 August 2022 Revised: 10 November 2022 Accepted: 14 November 2022 Published: 22 November 2022
  • Irritable bowel syndrome (IBS) is a common and disabling condition in children. The pathophysiology of IBS is thought to be multifactorial but remains incompletely understood. There is growing evidence implicating the gut microbiome in IBS. Intestinal dysbiosis has been demonstrated in paediatric IBS cohorts; however, no uniform or consistent pattern has been identified. The exact mechanisms by which this dysbiosis contributes to IBS symptoms remain unknown. Available evidence suggests the imbalance produces a functional dysbiosis, with altered production of gases and metabolites that interact with the intestinal wall to cause symptoms, and enrichment or depletion of certain metabolic pathways. Additional hypothesised mechanisms include increased intestinal permeability, visceral hypersensitivity and altered gastrointestinal motility; however, these remain speculative in paediatric patients, with studies limited to animal models and adult populations. Interaction between dietary components and intestinal microbiota, particularly with fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs), has drawn increasing attention. FODMAPs have been found to trigger and worsen IBS symptoms. This is thought to be related to products of their fermentation by a dysbiotic microbial population, although this remains to be proven. A low-FODMAP diet has shown promising success in ameliorating symptoms in some but not all patients. There remains much to be discovered about the role of the dysbiotic microbiome in paediatric IBS.

    Citation: Alexandra S McHarg, Steven Leach. The role of the gut microbiome in paediatric irritable bowel syndrome[J]. AIMS Microbiology, 2022, 8(4): 454-469. doi: 10.3934/microbiol.2022030

    Related Papers:

    [1] Julian-Dario Rembe, Vivian-Denise Thompson, Ewa Klara Stuermer . Antimicrobials cetylpyridinium-chloride and miramistin demonstrate non-inferiority and no “protein-error” compared to established wound care antiseptics in vitro. AIMS Microbiology, 2022, 8(4): 372-387. doi: 10.3934/microbiol.2022026
    [2] Anthonia O. Oluduro, Yetunde M. Adesiyan, Olumide O. Omoboye, Adebowale T. Odeyemi . Phenotypic and molecular characterization of Staphylococcus aureus from mobile phones in Nigeria. AIMS Microbiology, 2023, 9(3): 402-418. doi: 10.3934/microbiol.2023021
    [3] Afia Anjum, Jarin Tabassum, Sohidul Islam, A. K. M. Imrul Hassan, Ishrat Jabeen, Sabbir R. Shuvo . Deciphering the genomic character of the multidrug-resistant Staphylococcus aureus from Dhaka, Bangladesh. AIMS Microbiology, 2024, 10(4): 833-858. doi: 10.3934/microbiol.2024036
    [4] Alaa Fathalla, Amal Abd el-mageed . Salt tolerance enhancement Of wheat (Triticum Asativium L) genotypes by selected plant growth promoting bacteria. AIMS Microbiology, 2020, 6(3): 250-271. doi: 10.3934/microbiol.2020016
    [5] Babak Elyasi Far, Mehran Ragheb, Reza Rahbar, Ladan Mafakher, Neda Yousefi Nojookambari, Spyridon Achinas, Sajjad Yazdansetad . Cloning and expression of Staphylococcus simulans lysostaphin enzyme gene in Bacillus subtilis WB600. AIMS Microbiology, 2021, 7(3): 271-283. doi: 10.3934/microbiol.2021017
    [6] Yuya Uehara, Yuko Shimamura, Chika Takemura, Shiori Suzuki, Shuichi Masuda . Effects of cosmetic ingredients on growth and virulence factor expression in Staphylococcus aureus: a comparison between culture medium and in vitro skin model medium. AIMS Microbiology, 2025, 11(1): 22-39. doi: 10.3934/microbiol.2025002
    [7] McKenna J. Cruikshank, Justine M. Pitzer, Kimia Ameri, Caleb V. Rother, Kathryn Cooper, Austin S. Nuxoll . Characterization of Staphylococcus lugdunensis biofilms through ethyl methanesulfonate mutagenesis. AIMS Microbiology, 2024, 10(4): 880-893. doi: 10.3934/microbiol.2024038
    [8] Tomokazu Shoji, Ryusei Muto, Ryoko Sakai, Hiroki Matsumura, Takashi Uchida, Fumihiko Kitta, Osamu Inoue, Keishi Kawata, Manabu Akazawa . Estimated medical costs of methicillin-resistant Staphylococcus aureus infection classified by polymerase chain reaction-based open reading frame typing in Japan. AIMS Microbiology, 2022, 8(4): 528-543. doi: 10.3934/microbiol.2022034
    [9] Makayla Schissel, Rebecca Best, Shelby Liesemeyer, Yuan-De Tan, Darby J. Carlson, Julie J. Shaffer, Nagavardhini Avuthu, Chittibabu Guda, Kimberly A. Carlson . Effect of Nora virus infection on native gut bacterial communities of Drosophila melanogaster. AIMS Microbiology, 2021, 7(2): 216-237. doi: 10.3934/microbiol.2021014
    [10] Ogueri Nwaiwu, Chiugo Claret Aduba . An in silico analysis of acquired antimicrobial resistance genes in Aeromonas plasmids. AIMS Microbiology, 2020, 6(1): 75-91. doi: 10.3934/microbiol.2020005
  • Irritable bowel syndrome (IBS) is a common and disabling condition in children. The pathophysiology of IBS is thought to be multifactorial but remains incompletely understood. There is growing evidence implicating the gut microbiome in IBS. Intestinal dysbiosis has been demonstrated in paediatric IBS cohorts; however, no uniform or consistent pattern has been identified. The exact mechanisms by which this dysbiosis contributes to IBS symptoms remain unknown. Available evidence suggests the imbalance produces a functional dysbiosis, with altered production of gases and metabolites that interact with the intestinal wall to cause symptoms, and enrichment or depletion of certain metabolic pathways. Additional hypothesised mechanisms include increased intestinal permeability, visceral hypersensitivity and altered gastrointestinal motility; however, these remain speculative in paediatric patients, with studies limited to animal models and adult populations. Interaction between dietary components and intestinal microbiota, particularly with fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs), has drawn increasing attention. FODMAPs have been found to trigger and worsen IBS symptoms. This is thought to be related to products of their fermentation by a dysbiotic microbial population, although this remains to be proven. A low-FODMAP diet has shown promising success in ameliorating symptoms in some but not all patients. There remains much to be discovered about the role of the dysbiotic microbiome in paediatric IBS.


    Abbreviations

    IBS:

    irritable bowel syndrome; 

    IBS-C:

    irritable bowel syndrome, constipation subtype; 

    IBS-D:

    irritable bowel syndrome, diarrhoea subtype; 

    IBS-M:

    irritable bowel syndrome, mixed constipation and diarrhoea subtype; 

    IBS-U:

    irritable bowel syndrome, unclassified; 

    FGID:

    functional gastrointestinal disorder; 

    rRNA:

    ribosomal ribonucleic acid; 

    SCFA:

    short chain fatty acid; 

    RCT:

    randomised controlled trial; 

    FODMAP:

    fermentable oligosaccharides, disaccharides, monosaccharides and polyols; 

    TACD:

    traditional American childhood diet

    Staphylococcus aureus is responsible for a multitude of infections, varying from minor skin and soft tissue infections to more complicated illnesses, such as bacteremia or endocarditis [1]. Recurring S. aureus bacteremia occurs in 10% of patients and can be as high as 15%, despite the use of antibiotics [2][4]. Current antibiotics are largely ineffective against chronic bacterial infections. Fifty percent of all infections are caused by biofilms [5]. These infections are extremely difficult to eradicate, and surprisingly, are often caused by drug-susceptible pathogens. It has been suggested this phenomenon is largely due to persister cells surviving antibiotic challenge within a biofilm [6],[7]. Persisters are traditionally defined as a phenotypic variant exhibiting a high degree of metabolic inactivity and tolerance to antibiotics [6],[8]. Tolerance, unlike resistance, is not passed on to progeny and is growth phase dependent. Recent work has elucidated the underlying mechanism of persister formation in S. aureus, but it remains unknown as to whether persisters have an advantage in evading the host immune response.

    Most of our knowledge on the interaction between persisters and the immune system comes from studies performed in Salmonella. In these studies, Salmonella persisters are able to skew macrophage polarization from a classically activated (M1) to an alternatively activated (M2) response promoting persister survival within the intracellular milieu [9]. Additionally, S. aureus biofilms also skew the macrophage response towards those with the M2 polarization, thus promoting persistence rather than clearance [10]. These studies support the idea of the immune system interacting with S. aureus persisters differently than non-persister counterparts, however direct evidence is lacking. Recent work in S. aureus has demonstrated that reactive oxygen species (ROS), which are often generated from cells closely associated with innate immunity, induce persister formation [11]. Additionally, S. aureus cells surviving antibiotic challenge within a macrophage were found to be persister cells [12]. Despite recent work demonstrating persisters are induced upon ROS exposure and survive within the macrophage during antibiotic challenge, it is unclear whether persisters have increased survival to innate immune components.

    Persister formation in S. aureus has been associated with decreased tricarboxylic acid (TCA) cycle activity, which consequently depletes intracellular ATP [8],[13]. Decreases in ATP likely affect the antibiotic targets within the bacterial cell, decreasing the cidal action exhibited by many antibiotics. Antimicrobial peptides (AMPs) are essential to the innate immune response and often share similar targets as antibiotics. Human AMPs that help control S. aureus dissemination include LL-37 and human β-defensin 3 (hβD3). LL-37 is found in the lysosome of macrophages and polymorphonuclear leukocytes (PMNs) and shares a similar antimicrobial activity with the antibiotic daptomycin [14]. LL-37 works by inserting into and forming pores in both the inner and outer membrane of the bacteria, thus disrupting their integrity [15]. The AMP, hβD3, is produced by epithelial cells and neutrophils and shares a similar antimicrobial activity with the antibiotic vancomycin, which works by targeting membrane-bound precursor lipid II [16]. The similarities shared by antibiotics and AMPs makes it plausible that persisters would also show tolerance to AMPs in addition to antibiotics. AMPs are commonly one of the first defenses to an invading pathogen and produced by most multicellular organisms, including invertebrates.

    Drosophila melanogaster, the common fruit fly, is considered a valuable tool for studying aspects of the vertebrate innate immune system. This is largely due to homology in genes associated with the innate immune system, in which ~80% of human immunity genes have homology within D. melanogaster [17]. Unlike vertebrates that have innate and adaptive immune response, D. melanogaster only contain an innate immune system [18]. This lack of an adaptive immune component allows for teasing apart whether persisters tolerate the innate immune response better than non-persister cells. Innate immunity is relatively conserved between vertebrates and invertebrates, including AMPs with D. melanogaster having both defensins and cathelicidins.

    The objectives of this study were to determine if TCA cycle mutants exhibit increased persister formation. From there, the interactions between the TCA cycle mutants and the innate immune system were further investigated, both when treated with AMPs in vitro and in a Drosophila sepsis infection.

    S. aureus strains used in this study were all derived from HG003, and all bacteria were grown in Tryptic Soy Broth (TSB) at 37 °C at 225 rpm. Defined bursa aurealis transposon mutants were acquired from the Nebraska transposon mutant library (transposon insertions designated by ::, Biodefense and Emerging Infections [BEI] Research Resources Repository, Manassas, VA). Transposon mutants were transduced into HG003 from LACJE2 using bacteriophage φ11.

    Overnight cultures were grown to mid-exponential phase in 12.5 mL TSB (125 mL) flask and challenged with either ciprofloxacin, oxacillin, or daptomycin (10, 10, 200 µg/mL, respectively). In the daptomycin assay, 50 µg/mL CaCl2 was added to ensure antibiotic activity. At each time point, 100 µL of culture was removed, pelleted by centrifugation, washed with 1% NaCl, serial diluted, and plated onto Tryptic Soy Agar (TSA) to enumerate surviving cells. As a control for survival defects, cultures were maintained in TSB and surviving cells were enumerated alongside treated cultures. For antimicrobial peptide time-dependent kill assays, cultures were grown to mid-exponential phase, centrifuged, resuspended in 1X phosphate buffered saline (PBS), and diluted again 1:25 in 1X PBS. Cultures were maintained in PBS due to the salt sensitivity of the antimicrobial peptides [19]. Following resuspension and dilution, cultures were challenged with either LL-37 or hβD3 (2.5 µg/mL and 5 µg/mL, respectively). Cultures were also maintained in 8 µg/mL chloramphenicol to prevent regrowth of resistant mutants. As a control for growth, cultures were also maintained only in the presence of chloramphenicol and survivors were enumerated alongside treated cultures.

    To confirm membrane potential is needed for daptomycin and LL-37 antimicrobial activity, the BacLight Bacterial Membrane Potential Kit (Invitrogen™ B34950, Waltham, MA) was used according to manufacturer's instructions in combination with flow cytometry. Cultures were grown to exponential phase and DiOC2 was excited at 488 nm. Green and red fluorescence was detected with bandpass filters of 515/20- and 616/23-nm, respectively. As a positive control, carbonyl cyanide m-chlorophenylhydrazone (CCCP), a proton-ionophore, was added to dissipate membrane potential.

    Once CCCP was confirmed to dissipate membrane potential, persister assays were performed as above with the following modifications. Following growth to mid-exponential phase (~4.5 h), carbonyl cyanide m-chlorophenylhydrazone (CCCP), a proton-ionophore, was added to dissipate membrane potential. CCCP was added at 20 µM for 10 minutes prior to antibiotic or antimicrobial peptide challenge [20]. After 10 minutes, cultures were centrifuged and washed twice with fresh media. Bacterial survival was enumerated over 72 h and 18 h for cells treated with daptomycin and LL-37, respectively.

    All adult files used were 1–2 days old and were reared on standard banana food at 25 °C with a diurnal light cycle. Flies were watched closely once pupation was evident. At the time of eclosion, flies were lightly etherized, separated by sex, and allowed to age for 24 hours. After maturing for 24 hours, flies were infected by septic pinprick as previously described [21]. Briefly, flies were anaesthetized with ether and pierced in the thorax with a Tungsten dissecting needle with a diameter of 1µm (Roboz Surgical Instrument Co, RS-6063, Gaithersburg, MD) dipped in an overnight culture (1 × 109 CFU/mL) of HG003, fumC::NΣ, or heat-killed HG003 resuspended in PBS. PBS was used as a wounding control. Once infected with approximately 104 CFU, flies were placed in pint cages and allowed one hour to recover. After one hour, those that had not woken up from the anesthesia were considered dead and discarded. Survival was monitored each day at approximately the same time for 15 days. 100 male and 100 female flies were used to determine mortality rates of D. melanogaster.

    Separate pint cages were set up to determine bacterial load of individual flies at specific time points (0 d, 3 d, 10 d, 14 d). Forty virgin males and forty virgin females were infected as previously stated for each treatment group. Once infected, individuals were given one hour to recover from anesthesia. After one hour, individuals that had not woken up were considered dead and removed. This point was also considered the start of the time course, and flies were aged to the appropriate time. Following incubation, flies were washed in 1X PBS, and placed into 100 µL of 1X PBS and homogenized using an RNase-free disposable pellet pestle (Fisher Scientific, 12-141-368, Waltham, MA) attached to a Pellet Pestle™ cordless motor (Fisher Scientific, 12-141-361, Waltham, MA). Following homogenization, the cultures were serial diluted and plated onto TSA for enumeration.

    Averages and standard deviations presented represent three biological replicates. Following D. melanogaster septic infection, a Kaplan-Meier survivorship analysis was performed to determine statistical significance. Significance was determined at p ≤ 0.05. Similarly, following bacterial enumeration from individual flies, statistical analysis was performed using a two-way ANOVA followed by a Tukey test. Significance was determined at p ≤ 0.05.

    To determine whether S. aureus persister cells can tolerate multiple classes of antibiotics, including those that may act in an energy-independent manner, antibiotic challenge experiments were performed with three antibiotics applied at 10- or 50-fold the minimal inhibitory concentration (MIC). As a control, survival in the absence of antibiotic treatment was monitored over 48 hours. All strains exhibit similar growth patterns, indicating there is no difference in survival when comparing TCA cycle mutants to wild-type S. aureus (Figure 1A). When ciprofloxacin, a DNA gyrase inhibitor, was added to the cultures at 10X MIC (MIC of 1 µg/mL), a decrease in CFU was observed in all strains (Figure 1B). However, fumC::NΣ exhibits approximately 1,000-fold more survival over a 48-hour timeframe than HG003 and gltA::NΣ (Figure 1B). In the presence of 10X MIC of oxacillin (MIC of 1 µg/mL), a b-lactam antibiotic binding to penicillin-binding proteins, live counts of all strains decreased by approximately 10-fold, with HG003 and gltA::NΣ continuing to decrease by three more orders of magnitude by 72 hours (Figure 1C). In contrast, fumC::NΣ displayed increased tolerance to oxacillin by 72 hours, as depicted by the characteristic plateau (Figure 1C). Finally, challenge with 50X MIC daptomycin (MIC of 4 µg/mL), an energy-independent pore-former, showed the most killing in the first 18 hours with HG003 and gltA::NΣ decreasing by approximately four orders of magnitude (Figure 1D). The fumC::NΣ strain again showed tolerance only decreasing by one order of magnitude by 48 hours (Figure 1D). When tested with multiple classes of antibiotics fumC::NΣ exhibited significantly more survival than wild-type HG003. Overall, these results demonstrate that interruption of the TCA cycle in the later steps results in increased tolerance to multiple classes of antibiotics.

    Figure 1.  Interruption of TCA cycle genes leads to an increase in persisters when treated with different classes of antibiotics. A) The fumC mutant (blue) shows no difference in CFU in the absence of antibiotic compared to wild-type HG003 (red) and a gltA mutant (purple). When treated with 10 µg/mL ciprofloxacin (10x MIC; B), 10 µg/mL oxacillin (10x MIC; C), or 200 µg/mL daptomycin (50x MIC; D) the fumC mutant showed a 100-1,000-fold increase in persisters after 48–72 hours of antibiotic challenge.

    Due to the similarity in mechanisms of antibiotics and antimicrobial peptides, it was hypothesized that interruption of late TCA cycle genes would result in tolerance to antimicrobial peptides. Antimicrobial peptide challenge was performed with LL-37 and hβD3. Under no antimicrobial peptide challenge, all strains exhibit similar survival indicating that the phenotype is a result of AMP treatment (Figure 2A). When LL-37 was added to the cultures, there was a decrease in CFU for HG003 and gltA::NΣ, with HG003 showing 100-fold decrease by 18 hours (Figure 2B). Interestingly, by 12 hours gltA::NΣ had begun showing a less of a phenotype with less than 0.5 log difference in survival (Figure 2B). As expected, fumC::NΣ exhibited AMP tolerance with less than a fold-change by 18 hours (Figure 2B). Upon hβD3 challenge HG003 exhibited a 1,000-fold decrease by 18 hours (Figure 2C). gltA::NΣ exhibited less of a phenotype (less than 0.5 log difference in survival) and fumC::NΣ exhibited tolerance with only a fold-change by 18 hours (Figure 2C). Overall, these results indicate that interruption of the TCA cycle in the later steps results in increased tolerance to AMPs, indicating that TCA cycle mutants are able to form persisters not only to antibiotics but also AMPs.

    Figure 2.  The fumC mutant has increased survival to antimicrobial peptides. Cultures were grown aerobically (1:10 volume to flask ratio in TSB) prior to dilution in PBS. Cultures were then left untreated (A) or challenged with 2.5 µg/mL LL-37 (B) or 5 µg/mL hβD3 (C). Surviving colonies were enumerated over the course of 18 hours. The fumC::NΣ strain (blue) exhibited increased survival after 18 hours when challenged with either antimicrobial peptide compared to HG003 (red) and gltA::NΣ (purple).

    It has been postulated that daptomycin is membrane potential dependent [22]. Similarly, LL-37 is also an ATP-independent pore former. CCCP has been used previously to dissipate membrane potential in Gram-negative bacteria. To investigate the mechanism of action of both daptomycin and LL-37, CCCP was utilized. To confirm that membrane potential was being disrupted in the same way in S. aureus, flow cytometry was utilized. Cultures of HG003 were either pre-treated with CCCP or left untreated and membrane potential was evaluated using the BacLight Bacterial Membrane Potential Kit. Cultures that were left untreated showed 92% of cells falling outside of the low membrane gate, indicating a higher membrane potential (Supplementary Figure 1). In contrast cultures that were pre-treated with CCCP showed 100% of cells falling within the low membrane gate, indicating a lower membrane potential (Supplementary Figure 1). This indicates that CCCP was dissipating membrane potential within S. aureus.

    Daptomycin is a membrane-acting antibiotic that has been hypothesized to be dependent on membrane potential [23]. To determine whether daptomycin and LL-37 killing is membrane-potential dependent, cultures were treated with CCCP to dissipate membrane potential. Following treatment with CCCP alone there was no significant change in survival after 72 hours, indicating that CCCP alone does not affect the viability of HG003 (Figure 3A). As seen previously, when HG003 was challenged with daptomycin, there was a decrease in CFU, resulting in a 106-fold decrease by 72 hours (Figure 3A). However, when daptomycin challenge was combined with CCCP pretreatment, increased tolerance was exhibited compared to daptomycin challenge in the absence of CCCP, as shown by the plateau starting at 24 hours post-challenge (Figure 3A).

    LL-37 has a similar mechanism to the proposed mechanism of daptomycin [15]. Therefore, cultures challenged with LL-37 were also treated with CCCP to dissipate membrane potential. As seen previously, CCCP alone has no significant effect on HG003 (Figure 3B). However, when LL-37 challenge was combined with CCCP treatment tolerance was exhibited, as shown by the increase in population survival (Figure 3B). These data suggest that both daptomycin and LL-37 are membrane potential dependent. Therefore, dissipating the membrane potential to eukaryotic levels increases persisters by approximately 1,000-fold and 10-fold, respectively.

    Figure 3.  Disrupting membrane potential confers protection against daptomycin and LL-37. Carbonyl cyanide m-chlorophenylhydrazone (CCCP) was added at 20 µM for 10 minutes prior to daptomycin (200 µg/mL daptomycin, A) or LL-37 (2.5 µg/mL, B) challenge. Untreated HG003 (red) had similar survival after 18 hours compared to cultures treated with CCCP alone (purple). Challenging HG003 with either daptomycin (green) or LL-37 (green) results in five or three logs killing, respectively. Treating HG003 with CCCP prior to either daptomycin (blue) or LL-37 (blue) challenge increased survival by either three or one log(s), respectively.

    D. melanogaster have been previously shown as a model for S. aureus infection through pricking the dorsal thorax. Previous studies have utilized MSSA and MRSA strains of S. aureus to investigate host-pathogen interactions [24],[25]. However, no long-term studies evaluating S. aureus persisters in D. melanogaster have been performed. Therefore, survival and bacterial enumeration were monitored in both males and females. Upon Kaplan-Meier survival analysis, it was determined that survival was statistically significant between males infected with HG003 and males infected with fumC::NΣ, resulting in males infected with fumC::NΣ dying sooner than those infected with wild-type HG003 (Figure 4; p = 0.026). Survival was also determined to be statistically significant between females infected with HG003 and females infected with fumC::NΣ, resulting in females infected with fumC::NΣ dying sooner than those infected with wild-type HG003 (Figure 5; p = 0.00097). However, there was no difference in survival between sexes challenged with the same strain (Figures S2 and S3; p = 0.12 and p = 0.49, respectively). Taken together these results suggest that TCA cycle mutants better survive the innate immune system within D. melanogaster.

    Figure 4.  D. melanogaster males infected with fumC::NΣ exhibit increased mortality. Newly eclosed males (n = 100) were allowed to mature for 24 hours and then pricked in the thorax with a Tungsten needle dipped in an inoculum of wild-type HG003 (blue) or fumC::NΣ (red). Males infected with fumC::NΣ exhibit decreased survival when analyzed by a Kaplan-Meier survival curve, p = 0.026.
    Figure 5.  D. melanogaster females infected with fumC::NΣ exhibit increased mortality. Newly eclosed females (n = 100) were allowed to mature for 24 hours and then pricked in the thorax with a Tungsten needle dipped in an inoculum of wild-type HG003 (blue) or fumC::NΣ (red). Females infected with fumC::NΣ exhibit decreased survival when analyzed by a Kaplan-Meier survival curve, p = 0.00097.

    Due to the increased mortality exhibited by D. melanogaster infected with fumC::NΣ and the increased tolerance to AMPs exhibited by fumC::NΣ, it was postulated that these flies would have increased bacterial burden due to their inability to clear the infection. Persisters have been examined within a mouse biofilm infection; however, persister survival within a septic infection remain unstudied [26]. Males infected with fumC::NΣ showed an increased bacterial load at three days post infection (2 logs) and 14 days post infection (1 log; Figure 6A; p =< 0.0001 and p = 0.0178, respectively). Similarly, females infected with fumC::NΣ showed an increase in bacterial load at 10 days post infection (1 log) and 14 days post infection (2 logs; Figure 6B; p = 0.0008 and p = 0.0212, respectively). Previously, it was shown that increased sexual activity can reduce male immunity and seminal fluid components can reduce female immunity [21],[27]. Therefore, Drosophila that had not mated were used to examine whether there is a sex bias. However, in Drosophila infected with wild-type HG003 there was no significant difference found between sexes at any time point post infection (Figure S4A). In Drosophila infected with fumC::NΣ males exhibited higher bacterial load at three days post infection (p = 0.0034), but females exhibited higher bacterial load at 10 days post infection (Figure S4B; p = 0.0415). Overall, these results suggest that TCA cycle mutants increase mortality within D. melanogaster because of increased bacterial burden during the course of infection.

    Figure 6.  D. melanogaster infected with fumC::NΣ show an increased bacterial load. D. melanogaster were infected with either wild-type HG003 or fumC::NΣ using the pinprick method. Both males and females infected with fumC::NΣ show an increase in bacterial burden. Males infected with fumC::NΣ (blue horizontal line) have significantly higher bacterial burden at three days post infection and 14 days post infection when compared to males infected with HG003 (red horizontal line) (p =< 0.0001 and p = 0.0178; A). Females infected with fumC::NΣ (blue vertical line) have significantly more bacteria at 10 days post infection and 14 days post infection when compared to females infected with HG003 (red vertical line) (p = 0.0008 and p = 0.0212; B).

    The current study supported the hypothesis that TCA cycle mutants exhibit increased persister formation to both antibiotics and components of the innate immune system. This can be seen when cultures were challenged with both antibiotics and AMPs (Figures 1 and 2). Without antibiotic challenge there was no difference in growth between strains; thus there was no growth defect associated with either fumC::NΣ or gltA::NΣ.

    Persister formation within S. aureus is associated with ATP depletion [8]. Recently, it has been shown that fumC::NΣ exhibits depleted ATP in comparison with HG003 [13]. Therefore, this population should exhibit increased antibiotic tolerance. This phenotype can be seen by the increase in survival exhibited by the fumC::NΣ strain after both antibiotic and AMP treatment (Figures 2 and 4). Unsurprisingly, the gltA::NΣ strain did not exhibit the same phenotype. Previous work demonstrated that disruption of the gltA gene didn't have a reduction in ATP, likely from glutamate feeding into the TCA cycle at 2-oxoglutarate [13].

    Generally, antibiotics and AMPs selectively act on prokaryotic cells because they require targets that only these organisms possess, such as 30S ribosomal subunits and DNA gyrase [28],[29]. Antibiotics that work in these manners rely on ATP to work by disrupting energy-dependent targets [30]. However, there are a few antibiotics and AMPs, such as daptomycin and LL-37, that have been proposed to be independent of ATP concentrations, and instead, dependent on membrane potential. Eukaryotic cells have a low membrane potential when compared with bacterial cells, which allows for ATP-independent antibiotics and AMPs to select for the higher potential bacterial cells [31]. Wild-type populations that were susceptible to daptomycin and LL-37 challenge alone exhibit tolerance when pre-treated with CCCP to dissipate membrane potential (Figure 3). This is indicative that persister formation may also be dependent on membrane potential. Previous work has shown that TCA cycle mutants have decreased membrane potential in comparison to wild-type populations [32]. Recent work has applied similar concepts with metabolism independent antibiotics when trying to eradicate persisters. In E. coli, persisters were successfully eradicated using combinational approaches with antibiotics that are strongly- and weakly-dependent on metabolism, thus eliminated non-persister and persister cells, respectively [33]. This work represents unique strategies that may have to be used to successfully eliminate persisters moving forward.

    In addition to tolerance to antibiotics, fumC::NΣ exhibited increased tolerance to AMPs. Previously, LL-37 and hβD3 have been shown to be induced in cell culture by both MRSA and MSSA strains [34]. When treated with both LL-37 and hβD3, the fumC::NΣ mutant exhibited tolerance to both AMPs (Figure 2B and 2C). This is unlike a previous experiment in which similar concentrations of AMPs were added, but 100% of the bacteria were killed. This may be explained by a difference in starting CFU. Cultures within this study were treated at 107 CFU/mL; however, cultures within the previous study were treated at 105 CFU/mL. A difference of two logs in the starting CFU within the current study would decrease CFU/mL to below the level of detection. Persister formation is also growth phase dependent, with fewer persisters formed earlier in the growth phase. These differences offer a likely explanation for the differences in results.

    In addition to evaluating persister formation in response to AMPs, D. melanogaster were also utilized to determine whether persisters provide a survival advantage in vivo. Flies were not infected with a defined amount of inoculum but starting CFU per fly was determined an hour after infection, typically flies were infected with 104 CFU. Survival was monitored for 15 days, after which remaining flies were considered to have survived the infection. Preliminary data showed that flies remaining by 20 days had no signs of infection (data not shown), therefore, survival was determined at 15 days. It was determined that D. melanogaster infected with fumC::NΣ exhibited decreased longevity when compared with their counterparts infected with wild-type S. aureus. (Figures 4 and 5). Fruit flies share common innate immune components with humans, such as AMPs [24]. Therefore, it is possible that while this study tested the tolerance of persisters to human AMPs, this phenotype would continue across species. Interestingly, there was no sex bias observed between males and females infected with the same strain (Figures S2 and S3). It is widely known that mating influences not only female immune function but can also negatively impact male immune function in D. melanogaster [35][39]. However, the present study examined virgin males and females in order to eliminate the possibility of immune system suppression caused by mating. Therefore, when sexes infected with the same strain of S. aureus were compared, there was no difference in survival, indicating that immune suppression described previously is due solely to mating behavior.

    It was also seen that bacterial load was higher in flies infected with fumC::NΣ than compared to those infected with wild-type S. aureus (Figure 6 A and B). The phenotype displayed indicates that D. melanogaster infected with fumC::NΣ have a hard time clearing the infection. This is illustrated by the decrease in CFU per fly associated with a wild-type S. aureus infection, whereas CFU per fly associated with a fumC::NΣ infection remains relatively constant during the course of infection. It is also interesting to note that when comparing males and females infected with fumC::NΣ, males exhibit increased bacterial load at three days post infection, but females exhibit increased bacterial load at 10 days post infection (Figure S4B). Males mature more rapidly in most insect species, including Drosophila. D. melanogaster males reach age of sexual maturity at two days post eclosion unlike females that take four days [40]. Mature males will also begin to court other males in the absence of females [41]. Therefore, it is not unlikely that the males used within this study exhibited immune suppression due to courting behavior between each other. This study utilized D. melanogaster due to production of AMPs similar to those found in humans [42]. While tolerance was observed to AMPs in vitro and survival was decreased in vivo in those flies infected with fumC::NΣ, it is also possible that the phenotype observed in the D. melanogaster is due to other components of the D. melanogaster immune system, such as recognition by peptidoglycan recognition proteins (PGRPs) ultimately leading to phagocytosis by plasmatocytes [43].

    This study indicates that interruption of the TCA cycle, particularly in the later steps increases tolerance not only to antibiotics but also to AMPs. It also showed that persisters pose a problem for the innate immune system, specifically AMPs, and contribute to survival within a host. More research is needed to tease apart how persisters interact with other components of the innate immune system and contribute to increased mortality within a host.



    Conflict of interest



    All authors declare no conflicts of interest in this review.

    [1] Lacy BE, Mearin F, Chang L, et al. (2016) Bowel disorders. Gastroenterology 150: 1393-1407. e5. https://doi.org/10.1053/j.gastro.2016.02.031
    [2] Boronat AC, Ferreira-Maia AP, Matijasevich A, et al. (2017) Epidemiology of functional gastrointestinal disorders in children and adolescents: A systematic review. World J Gastroenterol 23: 3915-3927. https://doi.org/10.3748/wjg.v23.i21.3915
    [3] Varni JW, Bendo CB, Nurko S, et al. (2015) Health-related quality of life in pediatric patients with functional and organic gastrointestinal diseases. J Pediatr 166: 85-90.e82. https://doi.org/10.1016/j.jpeds.2014.08.022
    [4] Sagawa T, Okamura S, Kakizaki S, et al. (2013) Functional gastrointestinal disorders in adolescents and quality of school life. J Gastroenterol Hepatol 28: 285-290. https://doi.org/10.1111/j.1440-1746.2012.07257.x
    [5] Song SW, Park SJ, Kim SH, et al. (2012) Relationship between irritable bowel syndrome,worry and stress in adolescent girls. J Korean Med Sci 27: 1398-1404. https://doi.org/10.3346/jkms.2012.27.11.1398
    [6] Holtmann GJ, Ford AC, Talley NJ (2016) Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol 1: 133-146. https://doi.org/10.1016/S2468-1253(16)30023-1
    [7] Devanarayana NM, Rajindrajith S (2018) Irritable bowel syndrome in children: Current knowledge, challenges and opportunities. World J Gastroenterol 24: 2211-2235. https://doi.org/10.3748/wjg.v24.i21.2211
    [8] Barbara G, Grover M, Bercik P, et al. (2019) Rome foundation working team report on post-infection irritable bowel syndrome. Gastroenterology 156: 46-58.e47. https://doi.org/10.1053/j.gastro.2018.07.011
    [9] Krogsgaard LR, Engsbro AL, Bytzer P (2018) Antibiotics: a risk factor for irritable bowel syndrome in a population-based cohort. Scand J Gastroenterol 53: 1027-1030. https://doi.org/10.1080/00365521.2018.1500638
    [10] Scarpellini E, Giorgio V, Gabrielli M, et al. (2009) Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. J Pediatr 155: 416-420. https://doi.org/10.1016/j.jpeds.2009.03.033
    [11] Arumugam M, Raes J, Pelletier E, et al. (2011) Enterotypes of the human gut microbiome. Nature 473: 174-180. https://doi.org/10.1038/nature09944
    [12] Wu ZA, Wang HX (2019) A systematic review of the interaction between gut microbiota and host health from a symbiotic perspective. SN Compr Clin Med 1: 224-235. https://doi.org/10.1007/s42399-018-0033-4
    [13] Malinen E, Rinttilä T, Kajander K, et al. (2005) Analysis of the fecal microbiota of irri table bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100: 373-382. https://doi.org/10.1111/j.1572-0241.2005.40312.x
    [14] Kassinen A, Krogius-Kurikka L, Mäkivuokko H, et al. (2007) The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133: 24-33. https://doi.org/10.1053/j.gastro.2007.04.005
    [15] Rajilić–Stojanović M, Biagi E, Heilig HG, et al. (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141: 1792-1801. https://doi.org/10.1053/j.gastro.2011.07.043
    [16] Chassard C, Dapoigny M, Scott KP, et al. (2012) Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther 35: 828-838. https://doi.org/10.1111/j.1365-2036.2012.05007.x
    [17] Jeffery IB, O'toole PW, Öhman L, et al. (2012) An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61: 997-1006. https://doi.org/10.1136/gutjnl-2011-301501
    [18] Casen C, Vebø H, Sekelja M, et al. (2015) Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther 42: 71-83. https://doi.org/10.1111/apt.13236
    [19] Pozuelo M, Panda S, Santiago A, et al. (2015) Reduction of butyrate-and methane-producing microorganisms in patients with irritable bowel syndrome. Sci Rep 5: 12693. https://doi.org/10.1038/srep12693
    [20] Tap J, Derrien M, Törnblom H, et al. (2017) Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology 152: 111-123. e118. https://doi.org/10.1053/j.gastro.2016.09.049
    [21] Saulnier DM, Riehle K, Mistretta TA, et al. (2011) Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141: 1782-1791. https://doi.org/10.1053/j.gastro.2011.06.072
    [22] Rigsbee L, Agans R, Shankar V, et al. (2012) Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 107: 1740-1751. https://doi.org/10.1038/ajg.2012.287
    [23] Hollister EB, Oezguen N, Chumpitazi BP, et al. (2019) Leveraging human microbiome features to diagnose and stratify children with irritable bowel syndrome. J Mol Diagn 21: 449-461. https://doi.org/10.1016/j.jmoldx.2019.01.006
    [24] Parkes G, Rayment N, Hudspith B, et al. (2012) Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil 24: 31-39. https://doi.org/10.1111/j.1365-2982.2011.01803.x
    [25] Paliy O, Rajakaruna S (2022) Development of Microbiota–Is the Process Continuing Through Adolescence?. Comprehensive Gut Microbiota.Elsevier 59-68. https://doi.org/10.1016/B978-0-12-819265-8.00022-X
    [26] Soergel DA, Dey N, Knight R, et al. (2012) Selection of primers for optimal taxonomic classification of environmental 16S rRNA gene sequences. The ISME J 6: 1440. https://doi.org/10.1038/ismej.2011.208
    [27] De Filippo C, Cavalieri D, Di Paola M, et al. (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci 107: 14691-14696. https://doi.org/10.1073/pnas.1005963107
    [28] Krogius-Kurikka L, Lyra A, Malinen E, et al. (2009) Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BioMed Cent Gastroenterol 9: 95. https://doi.org/10.1186/1471-230X-9-95
    [29] Moustafa A, Li W, Anderson EL, et al. (2018) Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease. Clin Transl Gastroenterol 9: e132. https://doi.org/10.1038/ctg.2017.58
    [30] Yatsunenko T, Rey FE, Manary MJ, et al. (2012) Human gut microbiome viewed across age and geography. Nature 486: 222-227. https://doi.org/10.1038/nature11053
    [31] Shankar V, Homer D, Rigsbee L, et al. (2015) The networks of human gut microbe–metabolite associations are different between health and irritable bowel syndrome. ISME J 9: 1899-1903. https://doi.org/10.1038/ismej.2014.258
    [32] Tana C, Umesaki Y, Imaoka A, et al. (2010) Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 22: 512-e115. https://doi.org/10.1111/j.1365-2982.2009.01427.x
    [33] Vervier K, Moss S, Kumar N, et al. (2022) Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet. Gut 71: 1821-1830. https://doi.org/10.1136/gutjnl-2021-325177
    [34] Crouzet L, Gaultier E, Del'Homme C, et al. (2013) The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil 25: e272-e282. https://doi.org/10.1111/nmo.12103
    [35] Peng L, Li ZR, Green RS, et al. (2009) Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 139: 1619-1625. https://doi.org/10.3945/jn.109.104638
    [36] Dunlop SP, Hebden J, Campbell E, et al. (2006) Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 101: 1288-1294. https://doi.org/10.1111/j.1572-0241.2006.00672.x
    [37] De Palma G, Lynch MD, Lu J, et al. (2017) Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med 9: eaaf6397. https://doi.org/10.1126/scitranslmed.aaf6397
    [38] Ringel-Kulka T, Choi CH, Temas D, et al. (2015) Altered colonic bacterial fermentation as a potential pathophysiological factor in irritable bowel syndrome. Am J Gastroenterol 110: 1339-1346. https://doi.org/10.1038/ajg.2015.220
    [39] Hayes PA, Fraher MH, Quigley EM (2014) Irritable bowel syndrome: the role of food in pathogenesis and management. Gastroenterol Hepatol 10: 164-174.
    [40] Barrett JS, Gearry RB, Muir JG, et al. (2010) Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 31: 874-882. https://doi.org/10.1111/j.1365-2036.2010.04237.x
    [41] Murray K, Wilkinson-Smith V, Hoad C, et al. (2014) Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol 109: 110-119. https://doi.org/10.1038/ajg.2013.386
    [42] Major G, Pritchard S, Murray K, et al. (2017) Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome. Gastroenterology 152: 124-133.e122. https://doi.org/10.1053/j.gastro.2016.09.062
    [43] Sloan TJ, Jalanka J, Major GAD, et al. (2018) A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects. PLoS One 13: e0201410. https://doi.org/10.1371/journal.pone.0201410
    [44] Kashyap PC, Marcobal A, Ursell LK, et al. (2013) Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. Gastroenterology 144: 967-977. https://doi.org/10.1053/j.gastro.2013.01.047
    [45] Ong DK, Mitchell SB, Barrett JS, et al. (2010) Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 25: 1366-1373. https://doi.org/10.1111/j.1440-1746.2010.06370.x
    [46] Chumpitazi BP, McMeans AR, Vaughan A, et al. (2018) Fructans exacerbate symptoms in a subset of children with irritable bowel syndrome. Clin Gastroenterol Hepatol 16: 219-225.e211. https://doi.org/10.1016/j.cgh.2017.09.043
    [47] Halmos EP, Power VA, Shepherd SJ, et al. (2014) A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 146: 67-75.e65. https://doi.org/10.1053/j.gastro.2013.09.046
    [48] Böhn L, Störsrud S, Liljebo T, et al. (2015) Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology 149: 1399-1407. e1392. https://doi.org/10.1053/j.gastro.2015.07.054
    [49] Eswaran SL, Chey WD, Han-Markey T, et al. (2016) A randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D. Am J Gastroenterol 111: 1824-1832. https://doi.org/10.1038/ajg.2016.434
    [50] Staudacher HM, Lomer MCE, Farquharson FM, et al. (2017) A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores Bifidobacterium species: a randomized controlled trial. Gastroenterology 153: 936-947. https://doi.org/10.1053/j.gastro.2017.06.010
    [51] McIntosh K, Reed DE, Schneider T, et al. (2017) FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut 66: 1241-1251. https://doi.org/10.1136/gutjnl-2015-311339
    [52] Hustoft T, Hausken T, Ystad S, et al. (2017) Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterol Motil 29: e12969. https://doi.org/10.1111/nmo.12969
    [53] Wilson B, Rossi M, Kanno T, et al. (2018) Low FODMAP diet effect on IBS gastrointestinal microbiome and metabolites and prediction of response. Gut 67: A181-A182. https://doi.org/10.1136/gutjnl-2018-BSGAbstracts.360
    [54] Chumpitazi BP, Cope JL, Hollister EB, et al. (2015) Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther 42: 418-427. https://doi.org/10.1111/apt.13286
    [55] Chumpitazi BP, Hoffman KL, Smith DP, et al. (2021) Fructan-sensitive children with irritable bowel syndrome have distinct gut microbiome signatures. Aliment Pharmacol Ther 53: 499-509.
    [56] Bennet SMP, Bohn L, Storsrud S, et al. (2018) Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut 67: 872-881. https://doi.org/10.1136/gutjnl-2016-313128
    [57] Valeur J, Smastuen MC, Knudsen T, et al. (2018) Exploring gut microbiota composition as an indicator of clinical response to dietary FODMAP restriction in patients with irritable bowel syndrome. Dig Dis Sci 63: 429-436. https://doi.org/10.1007/s10620-017-4893-3
  • This article has been cited by:

    1. Mohammed Elbediwi, Jens Rolff, Metabolic pathways and antimicrobial peptide resistance in bacteria, 2024, 79, 0305-7453, 1473, 10.1093/jac/dkae128
    2. Trenten J. Theis, Trevor A. Daubert, Kennedy E. Kluthe, Kenan L. Brodd, Austin S. Nuxoll, Staphylococcus aureus persisters are associated with reduced clearance in a catheter-associated biofilm infection, 2023, 13, 2235-2988, 10.3389/fcimb.2023.1178526
    3. Shuji Gao, Yuxin Wang, Shuo Yuan, Jing Zuo, Wenjie Jin, Yamin Shen, Daniel Grenier, Li Yi, Yang Wang, Cooperation of quorum sensing and central carbon metabolism in the pathogenesis of Gram-positive bacteria, 2024, 282, 09445013, 127655, 10.1016/j.micres.2024.127655
    4. Cody J. Hastings, Maya V. Keledjian, Laura Palanker Musselman, Cláudia N. H. Marques, Manuela Raffatellu, Delayed host mortality and immune response upon infection with P. aeruginosa persister cells , 2023, 91, 0019-9567, 10.1128/iai.00246-23
    5. Natalia V. Kirienko, Yuanpu Peter Di, Editorial: Role of microbial biofilm in infections, 2023, 13, 2235-2988, 10.3389/fcimb.2023.1231607
    6. Samuel González-García, Aida Hamdan-Partida, Julia Pérez-Ramos, José Félix Aguirre-Garrido, Anaíd Bustos-Hamdan, Jaime Bustos-Martínez, Comparison of the bacterial microbiome in the pharynx and nasal cavity of persistent, intermittent carriers and non-carriers of Staphylococcus aureus , 2024, 73, 0022-2615, 10.1099/jmm.0.001940
    7. Dan Luo, Weile Xie, Shiwei Ma, Longlong Wang, Jianguo Zhu, Zhe Wang, A new perspective on the antimicrobial mechanism of linezolid against Staphylococcus aureus revealed by proteomics and metabolomics analysis, 2025, 65, 09248579, 107470, 10.1016/j.ijantimicag.2025.107470
  • Reader Comments
  • © 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2500) PDF downloads(174) Cited by(5)

Figures and Tables

Figures(1)  /  Tables(3)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog